Found 181 results[ Author] Title Year
Filters: Filter is [Clear All Filters]
Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India. Reproductive Health [Internet]. 2018;15(S1). https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-018-0531-6http://link.springer.com/content/pdf/10.1186/s12978-018-0531-6.pdf.
The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network’s first protocol: deep phenotyping in three sub-Saharan African countries. Reproductive Health. 2020;17(S1)..
The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) database: open-access data collection in maternal and newborn health. Reproductive Health. 2020;17(S1)..
PRECISE pregnancy cohort: challenges and strategies in setting up a biorepository in sub-Saharan Africa. Reproductive Health. 2020;17(S1)..
The contribution of qualitative research within the PRECISE study in sub-Saharan Africa. Reproductive Health. 2020;17(S1)..
Harnessing the PRECISE network as a platform to strengthen global capacity for maternal and child health research in sub-Saharan Africa. Reproductive Health. 2020;17(S1)..
Benchmarking the Hypertensive Disorders of Pregnancy. Pregnancy Hypertens. 2016;6(4):279-284..
Advocacy is essential to supporting women with pre-eclampsia. Obstet Med. 2017;10(1):33-35..
Advocacy organisations as partners in pre-eclampsia progress: patient involvement improves outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):523-36..
Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018;11:115-123..
Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique. Hypertension. 2017;69(3):469-474..
Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. Pregnancy Hypertens. 2019;15:42-50..
External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017;69(4):705-711..
Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665..
THE fullPIERS RISK PREDICTION MODEL FOR WOMEN WITH PRE-ECLAMPSIA: EXTERNAL VALIDATION, RECALIBRATION AND ADDED VALUE OF A NOVEL BIOMARKER (PLACENTAL GROWTH FACTOR). In 2017..
Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review. Hypertension. 2017;70(6):1228-1237..
Genes, epigenetics and miRNA regulation in the placenta. Placenta. 2017;52:127-133..
Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep. 2018;8(1):6342..
Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study). Eur J Obstet Gynecol Reprod Biol. 2016;206:105-113..
Utilization of maternal health care services and their determinants in Karnataka State, India. Reprod Health. 2016;13 Suppl 1:37..
Community perceptions of pre-eclampsia in rural Karnataka State, India: a qualitative study. Reprod Health. 2016;13 Suppl 1:35..
“Women and children last”—effects of the covid-19 pandemic on reproductive, perinatal, and paediatric health. BMJ [Internet]. 2020;:m2287. http://www.bmj.com/lookup/doi/10.1136/bmj.m2287https://syndication.highwire.org/content/doi/10.1136/bmj.m2287http://data.bmj.org/tdm/10.1136/bmj.m2287.
Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;36:83-102..
Moving beyond silos: How do we provide distributed personalized medicine to pregnant women everywhere at scale? Insights from PRE-EMPT. Int J Gynaecol Obstet. 2015;131 Suppl 1:S10-5..
Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project. J Obstet Gynaecol Can. 2012;34(10):917-926..
Pre-eclampsia: an update. Curr Hypertens Rep. 2014;16(8):454..
PRE-EMPT (PRE-eclampsia-Eclampsia Monitoring, Prevention and Treatment): A low and middle income country initiative to reduce the global burden of maternal, fetal and infant death and disease related to pre-eclampsia. Pregnancy Hypertens. 2013;3(4):199-202..
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219-27..
Improving maternal and perinatal outcomes in the hypertensive disorders of pregnancy: A vision of a community-focused approach. Int J Gynaecol Obstet. 2012;119 Suppl 1:S30-S34..